viewCronos Group Inc

Cronos stock swoons on a trio of downgrades to the cannabis-focused company

One analyst downgraded the stock to Sell, citing a 'soft start' to Canada's legal cannabis market

Hand holding up red downward arrow
Two analysts dropped the stock to Hold from Buy, and one shifted to Sell from Hold

Cronos Group Inc (TSX:CRON) (NASDAQ:CRON) shares fell Wednesday after a trio of downgrades hit the cannabis stock.

PI Financial's Jason Zandberg and Cormack’s Jesse Pytlak each rethought their bullishness on the Toronto firm, downshifting, respectively, to Neutral from Buy and to Market Perform from Speculative Buy.

Matt Bottomley of Canaccord went a step farther, cutting his rating to Sell from Hold, citing a “soft start” to Canada’s legal cannabis market.

READ: Buds & Duds: Cronos shares tumble, Newstrike Brands soars on results

The demerits come after the cannabis investment firm posted a fourth-quarter net loss of US$116 million, US$0.06 per share, on Tuesday, compared with a $0.01 profit the previous year.

The stock sank 10% to C$24.32 on the TSX and lost more than 10% to US$18.10 on the Nasdaq.

Quick facts: Cronos Group Inc

Price: 6.46 USD

Market: NASDAQ
Market Cap: $2.25 billion

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...



archTIS poised for strong growth as they look at multiple sectors for technology

archTIS LTD (ASX: AR9) CEO and Executive Director Daniel Lai joined Steve Darling from Proactive to share his direction for the company as they look to branch out with their technology. Lai telling Proactive some of the contracts they have signed including their first in the Education/Space...

8 hours, 59 minutes ago

2 min read